Safety of Telaprevir for Chronic Hepatitis C Virus Infection: A Meta-Analysis of Randomized Controlled Trials

Author： Qin Huimin Li Hongtao Zhou Xiaolin Feng Fang Shen Yanbing Tan Hongku Ye Feng Xie Yingchun

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.32, Iss.10, 2012-10, pp. : 665-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials

By Essex Margaret Noyes Zhang Richard Y Berger Manuela F Upadhyay Sameer Park Peter W

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 465-477

Informa Healthcare

Access to resources Recommend Favorite

Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson's Disease: Meta-Analysis of Randomized Controlled Trials

By Kulisevsky Jaime Pagonabarraga Javier

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 147-161

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials

By Liu Lin-Lin

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1521-1533

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism

Current Pharmaceutical Design, Vol. 11, Iss. 30, 2005-11 ,pp. : 3893-3918

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 595-608

Bentham Science Publishers

Access to resources Recommend Favorite